IN2014MU01184A - - Google Patents

Info

Publication number
IN2014MU01184A
IN2014MU01184A IN1184MU2014A IN2014MU01184A IN 2014MU01184 A IN2014MU01184 A IN 2014MU01184A IN 1184MU2014 A IN1184MU2014 A IN 1184MU2014A IN 2014MU01184 A IN2014MU01184 A IN 2014MU01184A
Authority
IN
India
Prior art keywords
cyclobenzaprine
salts
preparing
composition
release
Prior art date
Application number
Inventor
Moinuddin Syed
Vishal Omprakash Daga
Rahul Sudhakar Dabre
Girish Kumar Jain
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to IN1184MU2014 priority Critical patent/IN2014MU01184A/en
Priority to PCT/IB2015/051942 priority patent/WO2015150948A1/en
Publication of IN2014MU01184A publication Critical patent/IN2014MU01184A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention provides a process for preparing a modified release solid oral pharmaceutical composition comprising cyclobenzaprine or salts thereof. In particular, the present invention relates to a process for preparing modified release solid oral pharmaceutical composition comprising a single unit of mini-tablet comprising cyclobenzaprine or salts thereof in a matrix of one or more release modifying substances, which mini-tablet is coated with one or more water soluble and/or insoluble release modifying substances. The composition may provide extended and specific release of cyclobenzaprine or salts thereof to achieve therapeutically effective plasma concentration over a period of 24 hours to treat muscle spasm associated with painful musculoskeletal conditions when administered to a patient in need thereof. The invention further includes process of preparing such composition.
IN1184MU2014 2014-03-29 2015-03-17 IN2014MU01184A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN1184MU2014 IN2014MU01184A (en) 2014-03-29 2015-03-17
PCT/IB2015/051942 WO2015150948A1 (en) 2014-03-29 2015-03-17 Modified release solid oral pharmaceutical compositions of cyclobenzaprine or a salt thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1184MU2014 IN2014MU01184A (en) 2014-03-29 2015-03-17

Publications (1)

Publication Number Publication Date
IN2014MU01184A true IN2014MU01184A (en) 2015-10-02

Family

ID=54395511

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1184MU2014 IN2014MU01184A (en) 2014-03-29 2015-03-17

Country Status (1)

Country Link
IN (1) IN2014MU01184A (en)

Similar Documents

Publication Publication Date Title
MX2021002321A (en) Novel methods.
MX393855B (en) COMBINATION THERAPY INCLUDING A RAF INHIBITOR AND TRAMETINIB
MX2021000071A (en) Use of pridopidine to improve cognitive function and for treating alzheimer's disease.
PH12017500746B1 (en) Carbidopa and l-dopa prodrugs and their use to treat parkinson's disease
MX382162B (en) Pharmaceutical combinations for treating cancer
MX2020011099A (en) Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof.
PH12016502352A1 (en) Pharmaceutical composition
TW201613578A (en) Pharmaceutical combinations
MX381440B (en) PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ULCERATIVE COLITIS.
MA39765A (en) Pharmaceutical formulations of a pan-raf kinase inhibitor, processes for their preparation, and methods of use
ZA201704327B (en) Methods and compositions for treating brain diseases
FI3445351T3 (en) Acetyl-leucine or a pharmaceutically acceptable salt thereof for improved mobility
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
MX2020005438A (en) Abuse deterrent morphine sulfate dosage forms.
IN2014MU01184A (en)
IN2014MU01185A (en)
IN2014MU01186A (en)
IN2014MU01187A (en)
IN2013MU01155A (en)
MX385725B (en) PHARMACEUTICAL COMPOSITION INCLUDING SUMATRIPTAN FOR THE TREATMENT OF MIGRAINE.
IN2013MU01154A (en)
IN2013MU01249A (en)
IN2013MU01250A (en)
IN2013MU01248A (en)